EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN FRAIL PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION
Journal of the American College of Cardiology, 2018-03, Vol.71 (11), p.A290-A290 [Peer Reviewed Journal]2018 American College of Cardiology Foundation ;Copyright Elsevier Limited Mar 10, 2018 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/S0735-1097(18)30831-3
Full text available